Intas Pharmaceuticals
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at ~22% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US.
Basic Information
- Category: Pharmaceuticals
- Founded: 1984
- Headquarters: Ahmedabad, India
- Website: intaspharma.com
Documented Facts
- Phone: +91796157 7000 (No linked source recorded for this statement.)
- Email: generalqueries@intaspharma.com (No linked source recorded for this statement.)
Evidence and Sources
- Intas Pharmaceuticals — Official Site (official)
- Intas Pharmaceuticals on linkedin (social)
Citation Guidance
Explore Pharmaceuticals profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Intas Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/intas-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/intas-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/intas-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (84/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-27T17:51:03.720Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at ~22% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.